Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

TENX Tenax Therapeutics Inc

5,35

-0,18 (-3,25%)

10 Apr 2025 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Tenax Therapeutics Charts.

Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Tenax Therapeutics Charts.

News Tenax Therapeutics Inc

Form PRE 14A - Other preliminary proxy statements
Mittwoch 9 April 2025 (1 Tag vor) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 4 April 2025 (6 Tage vor) • Edgar (US Regulatory)

Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Montag 31 März 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 25 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 25 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Dienstag 25 März 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 12 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 6 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Tenax Therapeutics Announces $25 Million Private Placement
Mittwoch 5 März 2025 (1 Monat vor) • GlobeNewswire Inc.

Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
Mittwoch 5 März 2025 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 13 Dezember 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 13 Dezember 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Tenax Therapeutics Inc News-Artikel

Energy Select Sector SPDR

BNP Paribas (QX)

JP Morgan Chase

Deutsche Lufthansa

Gold vs US Dollar

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen